drugset / Trial / NCT00914368
Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis
Non-randomizedParallel-groupOpen-labelScreening
Summary
The primary objective of this study is to establish a cut off level of platelet inhibition that separates patients with or without previous stent occlusion with acute clinical onset while on aspirin and clopidogrel treatment within 6 months after coronary stenting for coronary artery disease.
Timeline
- Start
- 2009-01
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clopidogrel | Small molecule | 75 mg | — |